PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF MB12066 AFTER MULTIPLE ORAL ADMINISTRATIONS IN HEALTHY VOLUNTEERS

被引:0
|
作者
Park, S. [1 ]
Kim, S. [1 ]
Chung, I. [1 ]
Shin, S. [1 ]
Jang, I. [1 ]
Yoon, S. [1 ]
Lim, K. [1 ]
Yu, K. [1 ]
机构
[1] Seoul Natl Univ, Coll Med & Hosp, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S52 / S52
页数:1
相关论文
共 50 条
  • [21] Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers
    Yoon, Jangsoo
    Sharma, Vikas
    Harada, Akiko
    CLINICAL DRUG INVESTIGATION, 2024, 44 (05) : 319 - 328
  • [22] Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers.
    Abd-Elaziz, Khalid
    Kamphuisen, Pieter W.
    Lyssens, Christophe
    Reuvers, Mariska
    den Daas, Izaak
    Van Bockstaele, Femke
    Vercruysse, Kristof
    Ulrichts, Hans
    Baumeister, Judith
    Crabbe, Patricia
    Compernolle, Veerle
    Holz, Josefin-Beate
    BLOOD, 2009, 114 (22) : 439 - 440
  • [23] Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers
    Butler, Kathleen
    Teng, Renli
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (01) : 65 - 77
  • [24] Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers
    Xiao, Y.
    Lu, Y.
    Kang, Z.
    Hou, F.
    Wang, S.
    Li, T.
    Liu, Y.
    Xia, Y.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (04) : 172 - 179
  • [25] Pharmacokinetics, tolerability, and safety of pirfenidone (PFD), an antifibrotic agent, following single and multiple oral doses in healthy volunteers
    Shi, Shaojun
    Wu, Jianhong
    Chen, Huating
    Chen, Hui
    Wu, Jun
    Zeng, Fandian
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 197 - 197
  • [26] Pharmacokinetics, tolerability, and safety of ACP-103 following single or multiple oral dose administration in healthy volunteers
    Vanover, Kimberly E.
    Robbins-Weilert, Doris
    Wilbraham, Darren G.
    Mant, Timothy G. K.
    van Kammen, Daniel P.
    Davis, Robert E.
    Weiner, David M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (06): : 704 - 714
  • [27] Pharmacokinetics and Safety of Tedizolid after Single and Multiple Intravenous/Oral Sequential Administrations in Healthy Chinese Subjects
    Chen, Rui
    Shen, Kai
    Chang, Xinying
    Tanaka, Toshiaki
    Li, Li
    Hu, Pei
    CLINICAL THERAPEUTICS, 2016, 38 (08) : 1869 - 1879
  • [28] Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers
    Miceli, JJ
    Wilner, KD
    Swan, SK
    Tensfeldt, TG
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (06): : 620 - 630
  • [29] Single oral dose safety, tolerability, and pharmacokinetics of PNU-96391 in healthy volunteers
    Rodríguez, CA
    Azie, NE
    Adams, G
    Donaldson, K
    Francom, SF
    Staton, BA
    Bombardt, PA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (03): : 276 - 283
  • [30] Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers
    Park, Sang-In
    Oh, Jaeseong
    Jang, Kyungho
    Yoon, Jangsoo
    Moon, Seol Ju
    Park, Jong Sun
    Lee, Jae Ho
    Song, Junghan
    Jang, In-Jin
    Yu, Kyung-Sang
    Chung, Jae-Yong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) : 4429 - 4435